Caribou Biosciences Inc CRBU

$0.36 -0.02 (-4.81%)

Valuation

Market cap
41,076,000
Revenue TTM
$11,160,000
Net income TTM
$-148,130,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-1,327.33%
Debt to equity
0.00

Trading

Volume
1,738,600
Avg volume
3,247,370
Day's range
$0.36 – $0.38
Shares out
108,037,000
Stochastic %K
2%
Beta
2.50
Analysts
Moderate Buy
Price target
$5.60

Price

Company profile

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy...

Show more

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.

Industry
Biotechnology
Sector
Healthcare
Phone
510 982 6030
Website
https://cariboubio.com
Address
2929 7th Street, Suite 105, Berkeley, United States

Latest news

No headlines yet.

Stocktwits

Itsokman Nov 13, 4:19 PM
$CRBU NO PFIZER BUYOUT?!?!?!? I thought that was a slam dunk? Heh 🤠
0 replies
skyrockets_Inc Nov 12, 6:50 PM
$CRBU Added 100k more this AM, up to 600k total.
0 replies
Facade78 Nov 11, 5:30 PM
$CRBU still waiting for 0.30/0.32 to add
1 replies
skyrockets_Inc Nov 10, 6:00 PM
$CRBU Added 300k more shares today, up to 500k total. Will add another 100k likely tomorrow or Thur.
0 replies
BiotechGoldenEra Nov 10, 4:09 AM
$CRBU she dead
0 replies
quark_n_jaguar Nov 10, 3:40 AM
$CRBU Every day here without a deal or liquidation is a day where value gets burnt with no return— the money in executive compensation and other overhead reduces the already little money share holders will get. Stay away like plague :)
0 replies
skyrockets_Inc Nov 9, 5:13 PM
$CRBU Officially starting my position, 200k shares as of now at 0.44/share avg. Will add more if it drops. Latest 10Q is out and my math estimates from early Oct were scarily accurate. Updated numbers below. CRBU RM Valuation: --> 100m cash, -20m liability = 80m end of Q3 (Sept 30, 2026) --> -22m estimated Q4 burn, inclusive of restructuring costs --> -12m estimated early lease cancellation fee =46m cash remaining (Dec 31, 2026), starting point for merger valuation. Likely will bring ~35m of that to actual merger closing + NASDAQ shell (worth 10m) =Total valuation of ~45m for RM (108m shares OS) = 0.41/share FLOOR giving ZERO value to any legacy assets.
1 replies
Nitro111 Nov 7, 7:09 PM
$CRBU someone buy this POS
0 replies